载药微泡联合聚焦超声打开血脑屏障及局部递药治疗脑胶质瘤。
Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
机构信息
Biomedical Engineering and Environmental Science, National Tsing Hua University, Hsinchu 30013, Taiwan, ROC.
出版信息
Biomaterials. 2012 Jan;33(2):704-12. doi: 10.1016/j.biomaterials.2011.09.096. Epub 2011 Oct 22.
Glioblastoma multiforme (GBM) is a highly malignant brain tumor. The blood-brain barrier (BBB) provides a major obstacle to chemotherapy since therapeutic doses cannot be achieved by traditional drug delivery without severe systemic cytotoxic effects. Recently, microbubble (MB)-enhanced focused ultrasound (FUS) was shown to temporally and locally disrupt the BBB thereby enhancing drug delivery into brain tumors. Here we propose the concept of smart, multifunctional MBs capable of facilitating FUS-induced BBB disruption while serving as drug-carrying vehicles and protecting drugs from rapid degradation. The designed MBs had a high loading capacity (efficiency of 68.01 ± 4.35%) for 1,3-bis(2-chloroethyl)-1- nitrosourea (BCNU). When combined with FUS (1-MHz), these BCNU-MBs facilitated local BBB disruption and simultaneously released BCNU at the target site, thus increasing local BCNU deposition. Encapsulation of BCNU in MBs prolonged its circulatory half-life by 5-fold, and accumulation of BCNU in the liver was reduced 5-fold due to the slow reticuloendothelial system uptake of BCNU-MBs. In tumor-bearing animals, BCNU-MBs with FUS controlled tumor progression (915.3%-39.6%) and improved median survival (29 days-32.5 days). This study provides a new approach for designing multifunctional MBs to facilitate FUS-mediated chemotherapy for brain tumor treatment.
多形性胶质母细胞瘤(GBM)是一种高度恶性的脑肿瘤。血脑屏障(BBB)是化疗的主要障碍,因为传统的药物输送方法无法达到治疗剂量,而不会产生严重的全身细胞毒性作用。最近,微泡(MB)增强的聚焦超声(FUS)已被证明可以暂时和局部破坏 BBB,从而增强药物向脑肿瘤的输送。在这里,我们提出了智能多功能 MB 的概念,这些 MB 能够促进 FUS 诱导的 BBB 破坏,同时作为药物载体并保护药物免受快速降解。设计的 MB 对 1,3-双(2-氯乙基)-1-亚硝脲(BCNU)具有高载药能力(效率为 68.01±4.35%)。当与 FUS(1MHz)结合使用时,这些 BCNU-MB 促进了局部 BBB 破坏,同时在靶部位释放 BCNU,从而增加了局部 BCNU 沉积。BCNU 包封在 MB 中使其循环半衰期延长了 5 倍,由于 MB 的缓慢网状内皮系统摄取,BCNU 在肝脏中的积累减少了 5 倍。在荷瘤动物中,FUS 联合 BCNU-MB 控制肿瘤进展(915.3%-39.6%)并延长中位生存时间(29 天-32.5 天)。这项研究为设计多功能 MB 以促进 FUS 介导的化疗治疗脑肿瘤提供了一种新方法。